Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers
Completed · Not applicable
Conditions studied: Nicotine Dependence, Other Tobacco Product, Tobacco Use, Smoking, Tobacco
In brief
The JUUL 5% Electronic Nicotine Delivery System (ENDS) is being studied as an alternative to combustible cigarette use. This study aims to find out how much nicotine is in the blood and urine of healthy adult subjects after using three JUUL 5% ENDS compared to smoking usual brands of combustible cigarettes and stopping smoking.
Key facts
- Study ID
- NCT03463837
- Run by
- Juul Labs, Inc.
- People needed
- 90
- Starts
- 2018-03-04
- Expected to finish
- 2018-08-13
- Last updated by the study team
- 2021-06-21
Who can join
Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.